Replies to post #316788 on Anavex Life Sciences Corp (AVXL)

[infitvest]

The person who said that is on OLE on the active drug. Its the OLE's (active drug) that keep getting extended due to patient and caregiver request. That was what I was referencing.

[McMagyar]

All participants are given drug after trial..
20% of population doesn’t have S1r wild type(?). We should find a way to use
Placental stem cells to introduce S1r wild type (if possible) or maybe even Exosomes messaging of S1r wildtype to try amd creat effect for this 20%..